Related Experiment Video
Updated: Nov 4, 2025

11:54
Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
9.3K
Triploid pregnancy-Clinical implications
Diana Massalska1, Julia Bijok1, Anna Kucińska-Chahwan1
1Department of Gynecologic Oncology and Obstetrics, Centre of Postgraduate Medical Education, Warsaw, Poland.
Clinical Genetics
|May 25, 2021
Summary
Triploidy, a genetic condition with an extra chromosome set, impacts 1-2% of conceptions. Understanding its paternal or maternal origin is crucial for predicting pregnancy complications and guiding diagnosis.
Area of Science:
- Reproductive genetics
- Perinatology
- Medical diagnostics
Background:
- Triploidy is a severe genetic abnormality involving an extra haploid set of chromosomes, affecting 1-2% of all conceptions.
- It can originate from paternal (diandric triploidy) or maternal (digynic triploidy) chromosomes, significantly influencing pregnancy outcomes and maternal health.
- Most triploidy cases result in early miscarriage, highlighting the need for accurate early detection and management.
Purpose of the Study:
- To elucidate the clinical aspects of triploid pregnancies, emphasizing the impact of parental origin.
- To highlight diagnostic approaches, including ultrasound and biochemical markers.
- To discuss challenges in diagnosing partial hydatidiform mole associated with diandric triploidy and identify areas for future research.
Main Methods:
- Review of clinical data and literature on triploidy.
- Analysis of ultrasound and biochemical marker patterns for diagnosis.
- Discussion of molecular confirmation methods for parental origin determination.
Main Results:
- Parental origin of triploidy influences fetal phenotype and maternal complications like gestational trophoblastic neoplasia, hyperthyroidism, hypertension, and preeclampsia.
- Distinctive ultrasound features and biochemical markers aid in diagnosis.
- Early diagnosis of partial hydatidiform mole in diandric triploidy remains challenging due to limitations in histopathology and ultrasound.
Conclusions:
- Parental origin determination in triploidy is vital for risk assessment of maternal complications.
- Improved diagnostic tools are needed, especially for early-term pregnancy losses.
- Further research is required to address unresolved issues in triploidy management and diagnosis.
Related Concept Videos
Nondisjunction
4.3K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.3K
Nondisjunction
78.7K
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
78.7K
Meiosis vs. Mitosis
63.4K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
63.4K
Teratogenicity
3.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.4K
Meiosis I
199.2K
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
199.2K
Oogenesis
67.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
67.3K

